[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344974-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344974-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nanoformulated-phytochemicals-against-pancreatic-cancer-emerging-advances-in-therapeutic-strategies","Nanoformulated Phytochemicals Against Pancreatic Cancer - Emerging Advances in Therapeutic Strategies","","Scoping review analyzes recent advances in nanoformulated phytochemicals for pancreatic cancer, focusing on phytochemical-based nanostructures assessed in pancreatic cancer biological models. The review covers English-language studies from 2018 to 2025 and uses searches across Scopus, Web of Science, and PubMed, excluding non-pancreatic cancer focus, purely computational work, or phytochemical/nanoplatform studies not combined into nanoformulations. Findings synthesize 26 eligible preclinical studies spanning over 20 nanotechnological platforms, highlighting frequently used agents and outlining major translational limitations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nanoformulated-phytochemicals-against-pancreatic-cancer-emerging-advances-in-therapeutic-strategies/344974/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nanoformulated-phytochemicals-against-pancreatic-cancer-emerging-advances-in-therapeutic-strategies/344974.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the objective of the scoping review?","Question",{"text":63,"@type":64},"To analyze the most recent advances in the application of nanoformulated phytochemicals against pancreatic cancer and assess their reported therapeutic strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What types of studies were included or excluded?",{"text":68,"@type":64},"Included were English-language articles from 2018–2025 reporting phytochemical-based nanoformulations and therapeutic evaluation in pancreatic cancer biological models. Excluded were studies focused on other cancers, purely computational analyses, or works that did not combine phytochemical and nanoplatform into a nanoformulation.",{"name":70,"@type":61,"acceptedAnswer":71},"What major conclusions and limitations are highlighted?",{"text":72,"@type":64},"Phytochemical-containing nanoformulations show considerable promise, but many studies have limitations such as limited translatability from preclinical models to humans and a lack of standardized nanoformulation preparation methods.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344974,1790119353,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","International Journal of Nanomedicine  \n Open Access Full Text Article  \nREVIEW  \nNanoformulated Phytochemicals Against Pancreatic Cancer: Emerging Advances in Therapeutic Strategies  \nLuis Alberto Bravo-Vázquez 1 , Ana Paola Rochefort García 1 , Karla Andrea Maciel-Alemán 1 , Giovanni Emmanuel Rodríguez-González 1 , Padmavati Sahare2 , Gabriel Luna-Bárcenas2 , Asim K Duttaroy 3 , Sujay Paul 1  \n1School of Engineering and Sciences, Tecnologico de Monterrey, Campus Querétaro, Santiago de Querétaro, Querétaro, Mexico; 2Institute of Advanced Materials for Sustainable Manufacturing, Tecnologico de Monterrey, Campus Querétaro, Santiago de Querétaro, Querétaro, Mexico;  \n3Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway Correspondence: Asim K Duttaroy; Sujay Paul, Email [a.k.duttaroy@medisin.uio.no](a.k.duttaroy@medisin.uio.no); [spaul@tec.mx](spaul@tec.mx)  \n\n| Background: Pancreatic cancer (PC) is an aggressive malignancy that has become one of the leading causes of cancer-related death worldwide. Remarkably, phytochemical-based nanoformulations have demonstrated great potential in combating cancer progression. Therefore, the objective of this scoping review is to analyze the most recent advances in the application of nanoformulated phytochemicals against PC.\u003Cbr>Methods: This scoping review included English-language articles published between 2018 and 2025 that reported advances in the development of phytochemical-based nanoformulations and their therapeutic evaluation in PC biological models. On the contrary, nanoformulation studies focused on cancers other than PC were excluded, as were those based solely on computational analyses or addressing a phytochemical or a nanoplatform without combining both into a nanoformulation. Different types of scientific communication, such as reviews, book chapters, commentaries, and news, were not considered. The literature searches were conducted across 6 databases, including Scopus, Web of Science, and PubMed.\u003Cbr>Results: In this work, 26 eligible studies with preclinical data encompassing more than 20 distinct nanotechnological platforms were reviewed. Most of the conclusions from these investigations were drawn from cell proliferation assays, primarily involving the PC cell lines PANC-1, MIA PaCa-2, and HPAF-II. A smaller subset of investigations supplemented these findings with data from xenograft PC models treated with phytochemical-loaded nanoformulations. Among the phytochemicals most frequently incorporated into the nanoformulations were paclitaxel, curcumin, lawsone, and sulforaphane.\u003Cbr>Conclusion: Phytochemical-containing nanoformulations hold considerable promise as innovative therapeutic alternatives for PC. However, many available studies present notable limitations, such as the use of preclinical models with limited translatability to humans and a lack of a standardized method for preparing nanoformulations. Therefore, further investigations are required to clarify the therapeutic efficacy, safety profile, pharmacodynamics, pharmacokinetics, and overall clinical potential of these nanotechnology-driven approaches. Keywords: pancreatic cancer, nanoformulation, phytochemicals, nanomedicine, anticancer therapy |\n| --- |\n| Introduction\u003Cbr>Pancreatic cancer (PC) is an aggressive and heterogeneous disease whose global incidence has been rising over the last years. The early stages of PC are usually asymptomatic, and the pancreas’s deep anatomical position is one of the leading causes of delayed diagnosis.1–3 During PC pathogenesis, tumors tend to invade nearby tissues rapidly and show limited responsiveness to both chemotherapy and radiotherapy.4,5 In 2022, PC accounted for 510,566 new cases and 467,005 deaths worldwide, making it the sixth most common cause of death from cancer.6 Further, in 2024, 66,440 new cases of PC and 51,750 PC-related deaths were estimated in the United States.7 Remarkably, by 2050, the inciden","cbCain91QnJ39JsX","https://ap.wps.com/l/cbCain91QnJ39JsX","pdf",6336268,29,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What is the objective of the scoping review?\",\"answer\":\"To analyze the most recent advances in the application of nanoformulated phytochemicals against pancreatic cancer and assess their reported therapeutic strategies.\"},{\"question\":\"What types of studies were included or excluded?\",\"answer\":\"Included were English-language articles from 2018–2025 reporting phytochemical-based nanoformulations and therapeutic evaluation in pancreatic cancer biological models. Excluded were studies focused on other cancers, purely computational analyses, or works that did not combine phytochemical and nanoplatform into a nanoformulation.\"},{\"question\":\"What major conclusions and limitations are highlighted?\",\"answer\":\"Phytochemical-containing nanoformulations show considerable promise, but many studies have limitations such as limited translatability from preclinical models to humans and a lack of standardized nanoformulation preparation methods.\"}]","Nanoformulated Phytochemicals Against Pancreatic Cancer - Emerging Advances in Therapeutic Strategies | PDF",1790056054,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7eb6b588e229b782348f3a0a37687c9.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a22f3344ef79f4c2ad0c9f321d17d935.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/752de95866c79a8492b4d4c708a22171.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b8d9a8a12e78f79a92c47dfc31ef8ff.webp",980,1268]